Wellster Healthtech Group

🎃👻 Halloween at Wellster Healthtech had it all—creative pumpkins, spooky costumes, and a bit of Halloween humor about Germany’s digital health sector! While navigating regulations in digital health might be seriously spooky, our pumpkin game was all fun! Our Berlin team showed off their carving skills, and Munich went with creative painted designs (apparently, no knives allowed!). Swipe through to see the results—because these pumpkins are definitely worth a look! 🎨🎃 #TeamWellster #Halloween2024 #OfficeFun #DigitalHealth #WellsterHealthtech #CreativityAtWork #FutureofHealth

A Milestone in Obesity Treatment: The New S3 Guidelines Set Standards for Modern Therapy Options The recently published S3 guidelines mark a major step forward in the treatment of obesity – a strong signal for innovation and patient safety. 🎉 1. Medication-Based Therapy Recognized: For the first time, the active ingredients Liraglutide and Semaglutide are officially recognized as part of obesity treatment. These so-called "weight-loss injections" not only aid in weight reduction but also support long-term weight management – a meaningful expansion in treatment options. 2. E-Health as a Key Component: The new guidelines highlight the role of digital therapy solutions, such as our obesity-treatment-platform GoLighter.de, which can significantly enhance treatment outcomes. Studies show that E-Health solutions not only support weight loss but also strengthen long-term success through targeted follow-up and digital support. 3. Focus on Safety and Trust: People affected by obesity now have a reliable framework to guide their treatment. However, these therapies should always be conducted under medical supervision. "The association's recommendations align with the results we have seen in over a year of treatments on GoLighter.de: Liraglutide and Semaglutide offer effective support for long-term weight control," explains Dr. Sven Jungmann, "With these guidelines, digital platforms like GoLighter now receive an 'official seal of approval' – an important step in guiding consumers towards trusted options and ensuring therapies are conducted safely." With these developments, an important precedent for the future of obesity treatment has been set. Together, we continue to work toward reducing stigma in obesity treatment and providing everyone with access to the best possible therapies! 💜 #Obesity #S3Guidelines #GoLighter #EHealth #MedicalInnovation #PatientSafety #WeightLossInjections #Health #FutureofHealth

📢 Empowering Women Through Information and Reproductive Rights 📢 The FRAUEN100 initiative has taken a significant step toward improving women's health in Germany, and we at Wellster Healthtech Group are proud to support it. Together with Prof Mandy Mangler, a valued member of our Medical Board, we have co-signed an open letter to the German Federal Government, calling for the repeal of restrictive regulations like HWG §9 and §10. But what do these regulations actually prevent? The HWG §9 and §10 laws place limitations on how medical products like the morning-after pill can be advertised and communicated. Specifically, they: 🚫 Restrict public information about over-the-counter medications, creating barriers to awareness about essential products. 📚 Limit educational outreach by prohibiting manufacturers from sharing detailed information on the safe use of medications like the morning-after pill. ❌ Perpetuate misconceptions, such as the belief that emergency contraception is an abortion pill, when in fact, it only delays ovulation. This lack of accessible information has serious consequences: 📊 73% of people don’t know that the morning-after pill is available over-the-counter. ❓ Almost 50% of women mistakenly think it's an abortion pill. 🤦♀️ The result is stigma and confusion around emergency contraception, limiting women's ability to make informed health decisions. As Mandy Mangler stated: "The morning-after pill is a vital medication, recognized by the World Health Organization, that delays ovulation and offers a crucial option for preventing unintended pregnancies. Ending the advertising ban would help destigmatize its use and address widespread misconceptions." T he government has promised to support self-determination, information freedom, and equality in its coalition agreement. Now is the time to deliver. Repealing the advertising ban would ensure that women can access the information they need to make empowered decisions. Let's join forces with initiatives like #Frauen100 to push for these essential reforms and advocate for women's health. We call on Lisa Paus, Karl Lauterbach and the Deutscher Bundestag to take immediate action. Read the letter here: https://lnkd.in/eZ7XWn4k #WellsterHealthtech #DigitalHealth #WomensHealth #HWG9 #HWG10 #MySummer #EmpowerWomen #InformationIsPower #Frauen100 #HealthcareInnovation #ReproductiveRights #OpenLetter

The German Obesity Congress in Cologne made one thing clear: Support for medication-based therapies is on the rise—a promising sign for us at golighter.de! With these medications now included in the new S3 guidelines, it’s a significant step toward recognizing obesity as a chronic condition. While surgical options are effective, offering long-term results, medication is becoming the preferred choice for many. It’s not just about weight loss—these treatments can also support patients before and after surgery, ensuring a more comprehensive approach to health. And the best part? Medications for obesity are safe, with most side effects being manageable and rare. The focus is shifting to what’s truly important: giving people the tools they need to take control of their health, wherever they are on their journey. Let’s keep pushing for better access to modern treatments and make sure no one is left behind! 💜 #ObesityAwareness #golighter #MedicationMatters #S3Guidelines #HealthcareInnovation #Wellster #futureofmedicine

It was a pleasure hosting the Cornell Executive MBA/MS in Healthcare Leadership students at Wellster Healthtech. Great insights shared by founder Nico Hribernik, and a big thanks to Anna Wierzchowski who initiated the session from Wellster side, and to Stefanie Kubanek, Marina Leonie Moskvina and Dr. Bettina Maisch for making the visit happen. Wishing the students continued success in shaping the #FutureOfHealthcare

🌟 A fantastic evening at the FRAUEN100 100 x Health event! 🌟 We were thrilled to have Prof. Mandy Mangler represent Wellster Healthtech Group, shedding light on critical issues surrounding women's health and digital access to care. One key topic Mandy addressed was the misinformation around emergency contraception and the need for better access to trusted digital services like MySummer. As Mandy said: "The morning-after pill is not a hormone bomb, nor is it an abortion pill. It simply delays ovulation and is safe for use, even multiple times. Women deserve access to this information, free of stigma." Shockingly, 50% of women don’t know that the morning-after pill is available over-the-counter at pharmacies. This highlights the urgent need to modernize restrictive regulations like HWG §9, which limits how we communicate about medical solutions. Reforms are essential to empower women with better (digital) access to health services. A huge thank you to all the incredible speakers and panelists for their inspiring contributions: Katja Burkard, highlighting the importance of the evening through FRAUEN100 and introducing the #nurwennichesweiss initiative. Shivaani Phillips, sharing international comparisons on emergency contraception. Ricarda Lang, Federal Chairwoman & Women's Policy Spokesperson, BÜNDNIS 90/DIE GRÜNEN. Roman Malessa, Chief Growth Officer, FAQ – The Better Health Group. Elena Carrière, actress and model. Moderated by the wonderful Nele Würzbach. Together, we are pushing boundaries and bringing women's health and digital access to the forefront! #WellsterHealthtech #DigitalHealth #Telemedicine #MySummer #WomensHealth #HWG9 #HealthcareInnovation #Frauen100xHealth #FutureofHealth

GoEasy is setting a new standard in the medical cannabis space – with a touch of humor! 🥦 With the market for medical cannabis rapidly expanding, GoEasy stands out by offering a safe way to cannabis, medically-supervised, and compliant with strict German standards. Unlike many other platforms, we ensure patients receive personalized, doctor-supervised care, from diagnosis to receiving their medication. In fact, we’ve even leaned into the humor around the "broccoli vs. cannabis" debate from German politics to get the message across: safe, professional care doesn’t have to be boring! Here’s what makes GoEasy unique: 🥦A comprehensive, therapeutic approach for patients with chronic conditions such as pain, insomnia, and anxiety. 🥦Personalized medical supervision by a team of doctors with experience in cannabis therapy. 🥦A seamless digital process, from diagnosis to home delivery, with no hidden fees or extra charges for prescriptions. Our mission is to make safe access to medical cannabis more widely available while maintaining the highest medical standards. Want to learn more? Check out our story and feature in W&V, Werben & Verkaufen https://lnkd.in/eg5tSmzk #MedicalCannabis #Telemedicine #DigitalHealth #CannabisTherapy #Goeasy #WellsterHealthtech

Woohoo! 🎉 Our men's health platform GoSpring has landed 4th place in the Jung von Matt STARTup Brand Awards in the Health category! This award is a huge nod to our mission of tackling men’s health issues like erectile dysfunction and making healthcare more accessible through telemedicine. 💡🚀 A big shoutout to our co-founder Dr. Manuel Nothelfer, who proudly accepted the award at yesterday’s event in Berlin. This win reflects the passion and hard work of the entire Wellster Healthtech Group. We’re just getting started on our journey to revolutionize men’s health! 🌍💙 #StartupBrandRanking24 #SBR24 #StartupBrandRanking #GoSpring #Telemedicine #MensHealth #DigitalHealth #Innovation #HealthTech #FutureofHealth

🌟 A Milestone Moment at the Urologist Congress 🌟 At the 76th DGU-Congress, we had the opportunity to showcase Wellster Healthtech and GoSpring. These days were about connecting with the finest urologists from across the field, exchanging ideas, and discussing the urgent need for innovation in healthcare. With fewer doctors available and a growing number of patients, the demand for digital solutions has never been clearer—especially in urology. Represented by Sisa Josefina Lema C. (Head of Medical Affairs), Prof. Dr. Christian Wülfing (Chief of Urology at Asklepios Klinik and Chair of our Medical Advisory Board), Büsra Kurt (Medical Quality Manager) and Johannes von Bueren, MD, we forged new connections but also had the privilege of presenting one of our key studies: Assessment of Patient Risk Profiles by a Male Sexual Health Direct-to-Consumer Prescription Platform: A Cross-Sectional Study. This study highlights the importance of personalized healthcare in men’s sexual health, a topic that is gaining traction in the evolving landscape of digital medicine. For those interested, you can access the full study here: https://lnkd.in/exMcsdVq A big thank you to everyone who stopped by our stand to engage with us. This is just the beginning of what telemedicine can achieve in urology! #Urology #Telemedicine #MensHealth #GoSpring #DigitalHealth #HealthInnovation #UrologyCongress #HealthcareTech #SexualHealth #FutureOfHealthcare Deutsche Gesellschaft für Urologie

🥦 Proudly Introducing Goeasy.de: Setting a New Standard for Medical Cannabis Therapy 🥦 We’re thrilled to announce the launch of Goeasy.de, a fully regulated, telemedical platform offering cannabis therapy to patients across Germany. While the cannabis market can often feel like the "wild west," with unregulated providers catering to recreational users, Goeasy.de is different. We provide a safe, medically-supervised solution for patients dealing with chronic conditions such as pain, insomnia, and spasticity. “At Wellster, we’re committed to giving patients access to treatments grounded in strong medical standards. Goeasy.de is designed to make high-quality, medically-backed cannabis therapy more accessible and safer for everyone,” says Dr. Manuel Nothelfer, co-founder of Wellster Healthtech. Key Highlights: ✔️Structured diagnosis and supervision for patients with serious medical needs. ✔️ Strict adherence to German medical standards, with a team of experienced doctors. ✔️ Relieves traditional practices, offering a flexible and secure digital solution. Learn more about how we’re making a difference at www.goeasy.de and check out our feature in Handelsblatt: https://lnkd.in/eEV86q-a #MedicalCannabis #Telemedicine #SafeCannabis #Goeasy #WellsterHealthtech #DigitalHealth